Table of contents

Research Article

• Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective. (1 January, 1982)
• The choice of, and the decision to apply, disease modifying drugs. (1 January, 1982)

  C G Barnes
• Immunosuppression and the rheumatic diseases. (1 January, 1982)

  A M Denman
• Differences among immunosuppressive agents. (1 January, 1982)

  G H Hitchings
• The comparative incidence of malignant disease in rheumatoid arthritics exposed to different treatment regimens. (1 January, 1982)

  B L Hazleman
• Long-term effects of azathioprine in rheumatoid arthritis. (1 January, 1982)

  M B Urowitz, H A Smythe, T Able, C S Norman, C Travis
• Interim observations on benefit/risk of azathioprine versus D-penicillamine in the treatment of rheumatoid arthritis. (1 January, 1982)

  J R Ward, H J Williams
• EULAR register of patients on immunosuppressive drugs. (1 January, 1982)

  A Kay
• The incidence of malignant disease in patients receiving cytotoxic therapy for rheumatoid arthritis. (1 January, 1982)

  A B Kirsner, S J Farber, R P Sheon, R I Finkel
• Side-effects of azathioprine treatment in rheumatoid arthritis: analysis of 10 years of experience. (1 January, 1982)

  F Speerstra, A M Boerbooms, L B van de Putte, H J van Beusekom, M W Kruijsen, J P Vandenbroucke
• Compliance and long-term effect of azathioprine in 65 rheumatoid arthritis cases. (1 January, 1982)

  P van Wanghe, J Dequeker
• Rheumatoid arthritis: treatment with azathioprine (IMURAN (R)). Clinical side-effects and laboratory abnormalities. (1 January, 1982)

  J K Whisnant, J Pelkey